Hyderabad: A Leap Forward for Digital Health

In a significant move for the digital health sector, Ekincare, a Hyderabad-based integrated digital health startup, announced a strategic investment from global healthcare giant MSD, also known as Merck & Co Inc of USA. This investment was made through MSD IDEA Studio Asia Pacific, an initiative by the MSD Global Health Innovation Fund (MGHIF).

Expanding Healthcare Horizons

The pre-Series-C funding round also saw participation from Ekincare’s existing investor, HealthQuad, a venture capital fund dedicated to healthcare innovation. With a total funding of $22 million since its inception in 2015, Ekincare plans to utilize this fresh capital to broaden its cashless OPD network and enhance AI-powered analytics. These advancements aim to improve preventive care, chronic disease management, and employee wellness outcomes.

A Visionary Partnership

"Healthcare in India is at a turning point. Lifestyle diseases are on the rise, demand for preventive care is growing, and digital solutions are becoming a necessity," said Kiran Kalakuntla, co-founder & CEO of Ekincare. He highlighted the partnership with MSD IDEA Studio and HealthQuad as a visionary step forward, combining expertise in medicines, vaccines, and digital health with Ekincare’s AI-driven, customer-centric approach to deliver personalized healthcare to millions.

Founding Vision and Future Goals

Founded in 2015 by Kiran Kalakuntla, Srikanth Samudrala, and Noel Coutinho, Ekincare leverages AI, data analytics, and telemedicine to make preventive healthcare more accessible and personalized. With partnerships with over 1,000 companies and a network of over 40,000 healthcare providers across India, Ekincare is poised to transform the healthcare landscape.